Benjamin B. Mull

522 total citations
12 papers, 410 citations indexed

About

Benjamin B. Mull is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Benjamin B. Mull has authored 12 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Benjamin B. Mull's work include Virus-based gene therapy research (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Cells and Metastasis (3 papers). Benjamin B. Mull is often cited by papers focused on Virus-based gene therapy research (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Cells and Metastasis (3 papers). Benjamin B. Mull collaborates with scholars based in United States, Austria and Netherlands. Benjamin B. Mull's co-authors include Manfred Herold, W. Aulitzky, C. Huber, Arthur L. Beaudet, Günther Gastl, J. Frick, Estuardo Aguilar-Córdova, Khandan Keyomarsi, Núria Morral and Claire Langston and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Benjamin B. Mull

12 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin B. Mull United States	11	174	132	131	89	50	12	410
Fionnuala B. Hickey Ireland	14	252 1.4×	55 0.4×	62 0.5×	186 2.1×	49 1.0×	23	597
Lisa Gallinaro Italy	16	306 1.8×	84 0.6×	98 0.7×	113 1.3×	68 1.4×	32	856
John J. Kanalas United States	12	252 1.4×	45 0.3×	30 0.2×	84 0.9×	17 0.3×	24	558
Manop Pithukpakorn Thailand	12	100 0.6×	57 0.4×	55 0.4×	64 0.7×	21 0.4×	37	327
Shoichi Koizumi Japan	9	157 0.9×	151 1.1×	45 0.3×	94 1.1×	8 0.2×	14	444
R. Flener Austria	13	107 0.6×	88 0.7×	32 0.2×	147 1.7×	29 0.6×	30	435
E.J.A. Gerritsen Netherlands	9	261 1.5×	168 1.3×	87 0.7×	105 1.2×	6 0.1×	16	471
G. Brittinger Germany	15	150 0.9×	144 1.1×	61 0.5×	143 1.6×	12 0.2×	49	648
Yulian Jiao China	15	129 0.7×	56 0.4×	53 0.4×	380 4.3×	55 1.1×	25	593
Chien‐Hsing Lin Taiwan	10	116 0.7×	89 0.7×	96 0.7×	15 0.2×	40 0.8×	21	366

Countries citing papers authored by Benjamin B. Mull

Since Specialization

Citations

This map shows the geographic impact of Benjamin B. Mull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin B. Mull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin B. Mull more than expected).

Fields of papers citing papers by Benjamin B. Mull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin B. Mull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin B. Mull. The network helps show where Benjamin B. Mull may publish in the future.

Co-authorship network of co-authors of Benjamin B. Mull

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin B. Mull. A scholar is included among the top collaborators of Benjamin B. Mull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin B. Mull. Benjamin B. Mull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Mull, Benjamin B., et al.. (2020). Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer. British Journal of Cancer. 122(6). 812–822. 12 indexed citations

Mull, Benjamin B., John V. Cox, Tuyen Bui, & Khandan Keyomarsi. (2009). Post-translational modification and stability of low molecular weight cyclin E. Oncogene. 28(35). 3167–3176. 10 indexed citations

Mull, Benjamin B., et al.. (2004). Activation of Cyclin-dependent Kinase 2 by Full Length and Low Molecular Weight Forms of Cyclin E in Breast Cancer Cells. Journal of Biological Chemistry. 279(13). 12695–12705. 27 indexed citations

Lee, Brendan, Peter J. Healy, Benjamin B. Mull, et al.. (1999). Hepatocyte gene therapy in a large animal: A neonatal bovine model of citrullinemia. Proceedings of the National Academy of Sciences. 96(7). 3981–3986. 44 indexed citations

O’Neal, Wanda K., Heshan Zhou, Núria Morral, et al.. (1998). Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressing α ₁ -Antitrypsin after Systemic Delivery. Human Gene Therapy. 9(11). 1587–1598. 90 indexed citations

Patejunas, Gerald, J. A. Dennis, P.J. Healy, et al.. (1998). Evaluation of gene therapy for citrullinaemia using murine and bovine models. Journal of Inherited Metabolic Disease. 21(S1). 138–150. 17 indexed citations

Veldhuis, G.J., Pax H.B. Willemse, J.G. Aalders, et al.. (1995). Recombinant human interleukin-3 to dose-intensify carboplatin and cyclophosphamide chemotherapy in epithelial ovarian cancer: a phase I trial.. Journal of Clinical Oncology. 13(3). 733–740. 12 indexed citations

D’Hondt, Véronique, Thierry Guillaume, Yves Humblet, et al.. (1994). Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: a pilot study.. PubMed. 13(3). 261–4. 15 indexed citations

D’Hondt, Véronique, Yves Humblet, Thierry Guillaume, et al.. (1993). Tolerance and Effectiveness of Combined Il-3 and G-csf in Collecting Peripheral-blood Progenitor Cells (pbpc) Following Disease-oriented Chemotherapy. Experimental Hematology. 21(8). 1170–1170. 1 indexed citations

10.

Aulitzky, W., Günther Gastl, Manfred Herold, et al.. (1989). Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma.. Journal of Clinical Oncology. 7(12). 1875–1884. 97 indexed citations

11.

Aulitzky, Walter E., Herbert Tilg, Manfred Herold, et al.. (1988). Enhanced Serum Levels of β-2-Microglobulin, Neopterin, and Interferon-γ in Patients Treated with Recombinant Tumor Necrosis Factor-α. Journal of Interferon Research. 8(5). 655–664. 12 indexed citations

12.

Troppmair, Jakob, K. Nachbaur, Manfred Herold, et al.. (1988). In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS).. PubMed. 74(3). 392–7. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact